Showing results (511-520 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|May 4, 2023
A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O Brett, Taronish D Dubash, Gabriela N Johnson, et al.
JCO Precision Oncology|May 17, 2023
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class RearrangementsJayastu Senapati, Elias Jabbour, Marina Konopleva, et al.
JCO Precision Oncology|August 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III TrialFrank A Sinicrope, Qian Shi, Aurelie Catteau, et al.
JCO Precision Oncology|August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic RelevanceKoichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
JCO Precision Oncology|May 15, 2020
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous MelanomaDomenico Bellomo, Suzette M Arias-Mejias, Chandru Ramana, et al.
JCO Precision Oncology|August 8, 2022
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-BPhilippe L Bedard, Shuli Li, Kari B Wisinski, et al.
JCO Precision Oncology|August 8, 2022
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic AdenocarcinomaWilliam J Chapin, Jacob E Till, Wei-Ting Hwang, et al.
JCO Precision Oncology|March 2, 2023
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference CentersEdurne Arriola, Reyes Bernabé, Rosario García Campelo, et al.
JCO Precision Oncology|May 28, 2020
21-Gene Recurrence Score Adds Significant Value for Grade 3 Breast Cancers: Results From a National CohortJ Bryan Iorgulescu, Rachel A Freedman, Susan C Lester, et al.
JCO Precision Oncology|June 13, 2020
Actionable gene alterations in an Asian population with triple-negative breast cancerMasayuki Nagahashi, YiWei Ling, Tetsu Hayashida, et al.
Pageof 140